Literature DB >> 12895696

The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry. Interaction between SPMG and HIV-1 rgp120 and CD4 molecule.

Geng Meiyu1, Li Fuchuan, Xin Xianliang, Li Jing, Yan Zuowei, Guan Huashi.   

Abstract

The potential targets of marine sulfated polymannuroguluronate (SPMG) involved in inhibition of HIV-1 entry were investigated by surface plasmon resonance and flow cytometry. Results indicated that binding of SPMG either to soluble oligomeric rgp120 or to complexed rgp120-sCD4 mainly resided in V3 loop region. In addition, SPMG was shown to be less accessible for sCD4 when sCD4 had pre-interacted with rgp120, though SPMG per se multivalently bound to sCD4 with relatively low affinity. While the pre-incubation of SPMG with rgp120 caused a partial blockade of rgp120 binding to sCD4, suggesting that SPMG either shared common binding sites on gp120 with sCD4 or masked the docking sites of gp120 for sCD4. Taken together, V3 domain was demonstrated to be the major site mediating interaction of SPMG with complexed rgp120-sCD4. It seems likely that SPMG binds to both rgp120 and sCD4, but has less accessibility for sCD4 when sCD4 has already bound to rgp120. Nevertheless, addition of SPMG either prior to or after the interaction of rgp120 with sCD4 may suppress rgp120 binding to sCD4. The exact pattern of this trimolecular complex formation at the cell membrane-anchored virus level requires further clarification.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12895696     DOI: 10.1016/s0166-3542(03)00068-8

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  21 in total

Review 1.  Marine pharmacology in 2003-4: marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Roberto G S Berlinck; Mark T Hamann
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2007-02-09       Impact factor: 3.228

2.  Interaction of the HIV-1 gp120 viral protein V3 loop with bacterial lipopolysaccharide: a pattern recognition inhibition.

Authors:  Andreja Majerle; Primoz Pristovsek; Mateja Mancek-Keber; Roman Jerala
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

3.  Antiviral activity of natural products extracted from marine organisms.

Authors:  Bushra Uzair; Zahra Mahmood; Sobia Tabassum
Journal:  Bioimpacts       Date:  2011-11-09

4.  Viral inhibitors derived from macroalgae, microalgae, and cyanobacteria: A review of antiviral potential throughout pathogenesis.

Authors:  Daman Reynolds; Michael Huesemann; Scott Edmundson; Amy Sims; Brett Hurst; Sherry Cady; Nathan Beirne; Jacob Freeman; Adam Berger; Song Gao
Journal:  Algal Res       Date:  2021-05-18       Impact factor: 4.401

Review 5.  The antiviral activities and mechanisms of marine polysaccharides: an overview.

Authors:  Wei Wang; Shi-Xin Wang; Hua-Shi Guan
Journal:  Mar Drugs       Date:  2012-12-12       Impact factor: 5.118

Review 6.  Potential anti-HIV agents from marine resources: an overview.

Authors:  Thanh-Sang Vo; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2010-11-29       Impact factor: 5.118

Review 7.  Antiviral Potential of Algae Polysaccharides Isolated from Marine Sources: A Review.

Authors:  Azin Ahmadi; Soheil Zorofchian Moghadamtousi; Sazaly Abubakar; Keivan Zandi
Journal:  Biomed Res Int       Date:  2015-09-21       Impact factor: 3.411

8.  Synergistic Effects of Sulfated Polysaccharides from Mexican Seaweeds against Measles Virus.

Authors:  Karla Morán-Santibañez; Lucia Elizabeth Cruz-Suárez; Denis Ricque-Marie; Daniel Robledo; Yolanda Freile-Pelegrín; Mario A Peña-Hernández; Cristina Rodríguez-Padilla; Laura M Trejo-Avila
Journal:  Biomed Res Int       Date:  2016-06-22       Impact factor: 3.411

9.  Inhibition of Influenza A Virus Infection by Fucoidan Targeting Viral Neuraminidase and Cellular EGFR Pathway.

Authors:  Wei Wang; Jiandong Wu; Xiaoshuang Zhang; Cui Hao; Xiaoliang Zhao; Guangling Jiao; Xindi Shan; Wenjing Tai; Guangli Yu
Journal:  Sci Rep       Date:  2017-01-17       Impact factor: 4.379

Review 10.  Potential anti-HPV and related cancer agents from marine resources: an overview.

Authors:  Shi-Xin Wang; Xiao-Shuang Zhang; Hua-Shi Guan; Wei Wang
Journal:  Mar Drugs       Date:  2014-04-03       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.